These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31973998)

  • 1. Slow your role: How slowing clozapine titration can prevent recurrent NMS.
    Nahmias R; Pison D; Kassam A; Anderson D
    Schizophr Res; 2020 Apr; 218():332-333. PubMed ID: 31973998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
    Weller M; Kornhuber J
    Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive in a Schizophrenic Patient With Neuroleptic Malignant Syndrome and Rhabdomyolysis.
    San Gabriel MC; Eddula-Changala B; Tan Y; Longshore CT
    J ECT; 2015 Sep; 31(3):197-200. PubMed ID: 25243752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
    Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
    J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.
    Stoudemire A; Clayton L
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):303-5. PubMed ID: 2577714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
    Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.